Sign In
Buy SRTS
$2.84
+0 (+0%)
At Close: Jun 03, 2026
Zacks Investment Ideas feature highlights: Edwards Lifesciences, Mesa Laboratories and Sensus Healthcare
01:01pm, Tuesday, 21'st Dec 2021 Zacks Investment Research
Zacks Investment Ideas feature highlights: Edwards Lifesciences, Mesa Laboratories and Sensus Healthcare
What History Shows Us About 2022 Market Returns
05:48pm, Monday, 20'th Dec 2021 Zacks Investment Research
What to Expect From the Markets In 2022
What History Shows Us About 2022 Market Returns
02:33pm, Monday, 20'th Dec 2021
What to Expect From the Markets In 2022
Best Momentum Stocks to Buy for December 17th
03:04pm, Friday, 17'th Dec 2021 Zacks Investment Research
EXPD, FORR, BLDR, and SRTS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 17, 2021.
Sensus Healthcare, Inc. (NASDAQ:SRTS) CEO Sells $100,856.18 in Stock
11:36am, Friday, 17'th Dec 2021 Transcript Daily
Sensus Healthcare, Inc. (NASDAQ:SRTS) CEO Joseph C. Sardano sold 13,969 shares of the businesss stock in a transaction that occurred on Tuesday, December 14th. The stock was sold at an average price of $7.22, for a total transaction of $100,856.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which []
Stephen Brad Cohen Sells 14,889 Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) Stock
11:36am, Friday, 17'th Dec 2021 Transcript Daily
Sensus Healthcare, Inc. (NASDAQ:SRTS) EVP Stephen Brad Cohen sold 14,889 shares of the companys stock in a transaction that occurred on Tuesday, December 14th. The stock was sold at an average price of $7.22, for a total value of $107,498.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which []
Best Momentum Stocks to Buy for December 17th
11:29am, Friday, 17'th Dec 2021
EXPD, FORR, BLDR, and SRTS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 17, 2021.
Sail Through the Choppy Market With These 3 Low-Beta Stocks
01:14pm, Thursday, 16'th Dec 2021 Zacks Investment Research
It is imperative to build a portfolio of low-beta stocks to sail through choppy market conditions. Amphastar (AMPH), Sanderson Farms (SAFM) and Sensus Healthcare (SRTS) are well poised to gain.
Sail Through the Choppy Market With These 3 Low-Beta Stocks
09:59am, Thursday, 16'th Dec 2021
It is imperative to build a portfolio of low-beta stocks to sail through choppy market conditions. Amphastar (AMPH), Sanderson Farms (SAFM) and Sensus Healthcare (SRTS) are well poised to gain.
Sensus Healthcare, Inc. (NASDAQ:SRTS) CEO Sells 13,969 Shares of Stock
10:28pm, Wednesday, 15'th Dec 2021 Dakota Financial News
Sensus Healthcare, Inc. (NASDAQ:SRTS) CEO Joseph C. Sardano sold 13,969 shares of the companys stock in a transaction on Tuesday, December 14th. The shares were sold at an average price of $7.22, for a total value of $100,856.18. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible []
Best Momentum Stocks to Buy for December 15th
03:01pm, Wednesday, 15'th Dec 2021 Zacks Investment Research
GES, AOSL, and SRTS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 15, 2021.
Best Momentum Stocks to Buy for December 15th
11:35am, Wednesday, 15'th Dec 2021
GES, AOSL, and SRTS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 15, 2021.
Insider Selling: Sensus Healthcare, Inc. (NASDAQ:SRTS) EVP Sells 22,633 Shares of Stock
10:16pm, Monday, 13'th Dec 2021 Dakota Financial News
Sensus Healthcare, Inc. (NASDAQ:SRTS) EVP Stephen Brad Cohen sold 22,633 shares of the businesss stock in a transaction dated Thursday, December 9th. The stock was sold at an average price of $7.81, for a total value of $176,763.73. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC []
Sensus Healthcare, Inc. (SRTS) Moves to Strong Buy: Rationale Behind the Upgrade
05:00pm, Monday, 13'th Dec 2021 Zacks Investment Research
Sensus Healthcare, Inc. (SRTS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term
Sensus Healthcare, Inc. (SRTS) Moves to Strong Buy: Rationale Behind the Upgrade
01:50pm, Monday, 13'th Dec 2021
Sensus Healthcare, Inc. (SRTS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term
